Protalix BioTherapeutics, Inc. ( PLX) - Stock Earnings
PLX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
PLX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.5 million USD | 9.1 million USD |
| 2026Q1 | 18.3 million USD | 33.8 million USD |
| 2026Q2 | 3.8 million USD | 19.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PLX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 8.3 million USD | 65.5 million USD |
| 2024 | 2.9 million USD | 53.4 million USD |
| 2025 | -6.6 million USD | 52.7 million USD |
| 2026 Est. | — | — |
PLX
Price: $2.62
Earnings Per Share: 0.23 USD
P/E Ratio: 10.17
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 637200
Market Capitalization: 220.0 million